SMAD3 and Hepatic fibrosis: In this study, we found that YCHD suppresses the protein expression of TGF-β1, p-Smad3 and p-ERK1/2, whereas DMN activates TGF-β1/Smad/ERK signalling to induce liver fibrosis in rats.